Provided by Tiger Trade Technology Pte. Ltd.

Vanguard Health Care ETF

315.31
+2.430.78%
Post-market: 315.310.00000.00%19:46 EDT
Volume:370.00K
Turnover:117.09M
Market Cap:18.97B
PE:34.23
High:318.31
Open:313.66
Low:313.41
Close:312.88
52wk High:330.75
52wk Low:263.00
Shares:60.18M
Float Shares:60.18M
Volume Ratio:1.79
T/O Rate:0.61%
Dividend:4.63
Dividend Rate:1.47%
EPS(TTM):9.21
EPS(LYR):41.51
ROE:3.75%
ROA:0.89%
PB:0.96
PE(LYR):7.60

Loading ...

Eli Lilly treatment of pancreatic cancer granted orphan designation

TIPRANKS
·
Oct 05

UnitedHealth Group Faces AG Paxton Investigation Over Coverage Practices

MT Newswires Live
·
Oct 05

UnitedHealth under investigation by Texas AG amid alleged unlawful practices

TIPRANKS
·
Oct 05

Merck & Co Inc Stock (MRK) Moved Down by 3.04% on Oct 5: What Investors Need To Know

TradingKey
·
Oct 05

TRex Bio Files for Nasdaq IPO

MT Newswires Live
·
Oct 05

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Oct 05

PMV Pharmaceuticals Adds Veteran Investor to Board

TIPRANKS
·
Oct 05

Exchange-Traded Funds, Equity Futures Down Pre-Bell Monday as Tech Stocks Normalize

MT Newswires Live
·
Oct 05

RYET to Enter Malaysian Healthcare Through Exclusive Cogni AI License to BioNexus Gene Lab

GlobeNewswire
·
Oct 05

Gate Bioscience Expands Collaboration and License Agreement with Lilly to Target Difficult-to-Drug Proteins

THOMSON REUTERS
·
Oct 05

Eli Lilly Presents New Ebglyss Data from Phase 3 ADorable-1 Pediatric Atopic Dermatitis Study at Fall Clinical 2026

Reuters
·
Oct 05

JPMorgan Adjusts Price Target on Merck & Co. to $165 From $150, Maintains Overweight Rating

MT Newswires Live
·
Oct 05

Wall Street's US$10 bil India hospital bet sparks a fight over bills

Ranjani Raghavan & Anto Antony / Bloomberg
·
Oct 05

Eli Lilly & Co (LLY) Gets a Buy from RBC Capital

TIPRANKS
·
Oct 03

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Oct 03

AbbVie Joins US Government Pilot to Test Drug Discount Rebates

Reuters
·
Oct 03

AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Oct 03

Abbvie-from Jan 1, 2027, Covered Entities to Submit Claims to GET 340B Pricing Through Beacon on 340B-Eligible Dispenses of Imbruvica, Linzess,Vraylar

THOMSON REUTERS
·
Oct 03

Abbvie - Approved to Participate in Federal 340B Rebate Model Pilot Program

THOMSON REUTERS
·
Oct 03

Former Eli Lilly Exec Sells Wyoming Estate for Close to $39.5 Million

Dow Jones
·
Oct 03